A complete durable response of vaginal clear cell carcinoma with pembrolizumab: A case report
Primary clear cell adenocarcinoma of the vagina represents a rare form of cancer historically correlated with in-utero diethylstibestrol (DES) exposure. Mainstay treatment modalities include surgery, radiation, and chemotherapy. There has been a growing interest in immunotherapy in the field of onco...
Saved in:
Main Authors: | Hector S. Porragas-Paseiro (Author), Saketh Guntupalli (Author), Jessie Xiong (Author), Ashley Greenwood (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pembrolizumab-induced cytokine release syndrome with severe encephalopathy in the setting of clear cell vaginal carcinoma: A case report
by: Samantha Metzger, et al.
Published: (2024) -
Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapy
by: Blair McNamara, et al.
Published: (2023) -
Rare case of chemotherapy-refractory metastatic vaginal squamous cell carcinoma with complete response to concurrent pembrolizumab and radiotherapy- case report and literature review
by: Jawaher Ansari, et al.
Published: (2021) -
Complete response of merkel cell carcinoma with brain metastases to pembrolizumab and radiotherapy: A case report
by: Ansgar Koechel, et al.
Published: (2021) -
Long-term durable responses after pembrolizumab immunotherapy for recurrent, resistant endometrial cancer
by: John K. Chan, et al.
Published: (2020)